1. Home
  2. CUE vs FAT Comparison

CUE vs FAT Comparison

Compare CUE & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • FAT
  • Stock Information
  • Founded
  • CUE 2014
  • FAT 2017
  • Country
  • CUE United States
  • FAT United States
  • Employees
  • CUE N/A
  • FAT N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • CUE Health Care
  • FAT Consumer Discretionary
  • Exchange
  • CUE Nasdaq
  • FAT Nasdaq
  • Market Cap
  • CUE 58.9M
  • FAT 49.8M
  • IPO Year
  • CUE 2018
  • FAT 2017
  • Fundamental
  • Price
  • CUE $0.64
  • FAT $2.16
  • Analyst Decision
  • CUE Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • CUE 3
  • FAT 1
  • Target Price
  • CUE $3.00
  • FAT $10.00
  • AVG Volume (30 Days)
  • CUE 163.7K
  • FAT 45.2K
  • Earning Date
  • CUE 05-12-2025
  • FAT 05-08-2025
  • Dividend Yield
  • CUE N/A
  • FAT 12.79%
  • EPS Growth
  • CUE N/A
  • FAT N/A
  • EPS
  • CUE N/A
  • FAT N/A
  • Revenue
  • CUE $7,991,000.00
  • FAT $582,704,000.00
  • Revenue This Year
  • CUE N/A
  • FAT $2.29
  • Revenue Next Year
  • CUE $25.99
  • FAT $5.81
  • P/E Ratio
  • CUE N/A
  • FAT N/A
  • Revenue Growth
  • CUE 13.83
  • FAT 10.63
  • 52 Week Low
  • CUE $0.45
  • FAT $2.11
  • 52 Week High
  • CUE $1.99
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CUE 37.72
  • FAT 33.71
  • Support Level
  • CUE $0.61
  • FAT $2.20
  • Resistance Level
  • CUE $0.71
  • FAT $2.55
  • Average True Range (ATR)
  • CUE 0.06
  • FAT 0.19
  • MACD
  • CUE -0.00
  • FAT -0.04
  • Stochastic Oscillator
  • CUE 17.84
  • FAT 0.00

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: